Differential prediction of high-sensitivity cardiac troponin-I, but not N-terminal pro-brain natriuretic peptide, in different pitavastatin doses on cardiovascular events in stable coronary artery disease

被引:1
作者
Mitsutake, Yoshiaki [1 ]
Ishii, Junnichi [2 ,3 ]
Fukumoto, Yoshihiro [1 ,17 ]
Ito, Sohei [1 ]
Kashiwabara, Kosuke [4 ]
Uemura, Kouhei [4 ]
Matsuyama, Yutaka [4 ]
Sugiyama, Yoichi [1 ]
Ozaki, Yukio [2 ]
Iimuro, Satoshi [5 ]
Iwata, Hiroshi [6 ]
Sakuma, Ichiro [7 ]
Nakagawa, Yoshihisa [8 ]
Hibi, Kiyoshi [9 ]
Hiro, Takafumi [10 ]
Hokimoto, Seiji [11 ]
Miyauchi, Katsumi [6 ]
Daida, Hiroyuki [6 ]
Shimokawa, Hiroaki [12 ]
Saito, Yasushi [13 ]
Kimura, Takeshi [14 ]
Matsuzaki, Masunori [15 ]
Nagai, Ryozo [16 ]
机构
[1] Kurume Univ, Div Cardiovasc Med, Sch Med, Kurume, Japan
[2] Fujita Hlth Univ, Dept Cardiol, Sch Med, Toyoake, Japan
[3] Toyota Auto Body Yoshiwara Clin, Toyota, Japan
[4] Univ Tokyo Hosp, Clin Res Promot Ctr, Data Sci Off, Tokyo, Japan
[5] Int Univ Hlth & Welf, Innovat & Res Support Ctr, Tokyo, Japan
[6] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan
[7] Caress Sapporo Hokko Mem Clin, Sapporo, Japan
[8] Shiga Univ Med Sci, Dept Cardiovasc Med, Otsu, Japan
[9] Yokohama City Univ, Med Ctr, Div Cardiol, Yokohama, Japan
[10] Nihon Univ, Dept Med, Div Cardiol, Sch Med, Tokyo, Japan
[11] Kumamoto Municipal Ueki Hosp, Kumamoto, Japan
[12] Int Univ Hlth & Welf, Narita, Japan
[13] Chiba Univ, Chiba, Japan
[14] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan
[15] St Hill Hosp, Ube, Japan
[16] Jichi Med Univ, Shimotsuke, Japan
[17] Kurume Univ, Div Cardiovasc Med, Sch Med, 67 Asahi Machi, Kurume 8300011, Japan
关键词
Cardiac biomarker; Statin; Coronary artery disease; Cardiovascular events; STATIN THERAPY; PRIMARY PREVENTION; VASCULAR EVENTS; ROSUVASTATIN; CHOLESTEROL; RISK; PARTICIPANTS; METAANALYSIS; PRAVASTATIN; REGRESSION;
D O I
10.1016/j.ijcard.2023.131138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study aimed to examine whether high-sensitivity cardiac troponin-I (hsTnI) and N-terminal probrain natriuretic peptide (NT-proBNP) could predict future major adverse cardiovascular events (MACE) in stable coronary artery disease (CAD) patients with high- or low-dose of pitavastatin. Methods: This was a case-cohort analysis of the REAL-CAD study, a randomized trial of high- or low-dose (4 or 1 mg/day) pitavastatin therapy in patients with stable CAD. We examined the MACE risk according to the quartile of hsTnI and NT-proBNP at baseline. Results: A total of 1336 and 1396 patients including 582 MACE cases were randomly examined into the hsTnI and NT-proBNP cohort, respectively. Both higher levels of hsTnI and NT-proBNP at baseline were significantly associated with increased risk of MACE (p < 0.001, respectively). When separately analyzed in statin dose, the higher marker levels were significantly associated with higher MACE risk in all cohorts (p < 0.001 in all cohorts). After multivariable adjustment, hsTnI levels were significantly associated with MACE risk in low-dose statin
引用
收藏
页数:11
相关论文
共 30 条
[1]   Coronary Vascular Function and Cardiomyocyte Injury A Report From the WISE-CVD [J].
AlBadri, Ahmed ;
Wei, Janet ;
Quesada, Odayme ;
Mehta, Puja K. ;
Xiao, Yi ;
Ko, Yi-An ;
Anderson, R. David ;
Petersen, John ;
Azarbal, Babak ;
Samuels, Bruce ;
Henry, Timothy D. ;
Cook-Wiens, Galen ;
Handberg, Eileen M. ;
Van Eyk, Jennifer ;
Pepine, Carl J. ;
Bairey Merz, C. Noel .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (12) :3015-3021
[2]  
Austen W G, 1975, Circulation, V51, P5
[3]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[4]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[5]   Analysis of case-cohort designs [J].
Barlow, WE ;
Ichikawa, L ;
Rosner, D ;
Izumi, S .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (12) :1165-1172
[6]   Evidence for Cardiomyocyte Renewal in Humans [J].
Bergmann, Olaf ;
Bhardwaj, Ratan D. ;
Bernard, Samuel ;
Zdunek, Sofia ;
Barnabe-Heider, Fanie ;
Walsh, Stuart ;
Zupicich, Joel ;
Alkass, Kanar ;
Buchholz, Bruce A. ;
Druid, Henrik ;
Jovinge, Stefan ;
Frisen, Jonas .
SCIENCE, 2009, 324 (5923) :98-102
[7]   Interpretation of the evidence for the efficacy and safety of statin therapy [J].
Collins, Rory ;
Reith, Christina ;
Emberson, Jonathan ;
Armitage, Jane ;
Baigent, Colin ;
Blackwell, Lisa ;
Blumenthal, Roger ;
Danesh, John ;
Smith, George Davey ;
DeMets, David ;
Evans, Stephen ;
Law, Malcolm ;
MacMahon, Stephen ;
Martin, Seth ;
Neal, Bruce ;
Poulter, Neil ;
Preiss, David ;
Ridker, Paul ;
Roberts, Ian ;
Rodgers, Anthony ;
Sandercock, Peter ;
Schulz, Kenneth ;
Sever, Peter ;
Simes, John ;
Smeeth, Liam ;
Wald, Nicholas ;
Yusuf, Salim ;
Peto, Richard .
LANCET, 2016, 388 (10059) :2532-2561
[8]   REDUCTION IN SERUM-CHOLESTEROL WITH PRAVASTATIN IMPROVES ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION IN PATIENTS WITH HYPERCHOLESTEROLEMIA [J].
EGASHIRA, K ;
HIROOKA, Y ;
KAI, H ;
SUGIMACHI, M ;
SUZUKI, S ;
INOU, T ;
TAKESHITA, A .
CIRCULATION, 1994, 89 (06) :2519-2524
[9]   High-Sensitivity Cardiac Troponin I and B-Type Natriuretic Peptide as Predictors of Vascular Events in Primary Prevention Impact of Statin Therapy [J].
Everett, Brendan M. ;
Zeller, Tanja ;
Glynn, Robert J. ;
Ridker, Paul M. ;
Blankenberg, Stefan .
CIRCULATION, 2015, 131 (21) :1851-+
[10]   High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease [J].
Ford, Ian ;
Shah, Anoop S. V. ;
Zhang, Ruiqi ;
McAllister, David A. ;
Strachan, Fiona E. ;
Caslake, Muriel ;
Newby, David E. ;
Packard, Chris J. ;
Mills, Nicholas L. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (25) :2719-2728